Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Biology
|
September 8, 2016
Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells
Colin Rae, Robert J Mairs
Oncotarget
|
February 19, 2019
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
Colin Rae, Robert J Mairs
Chirality
|
December 1, 2016
Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75
Colin Rae, John W Babich, Robert J Mairs
Nuclear Medicine and Biology
|
October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapy
Robert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
Nuclear Medicine and Biology
|
October 17, 2002
Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cells
Sean Carlin, Robert J Mairs, Phil Welsh, et al.
The Journal of Pharmacy and Pharmacology
|
July 23, 2008
Radiation quality-dependent bystander effects elicited by targeted radionuclides
Marie Boyd, Annette Sorensen, Anthony G McCluskey, et al.
Radiation Research
|
October 21, 2015
Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy
Colin Rae, Uwe Haberkorn, John W Babich, et al.
Cancer Letters
|
June 7, 2005
[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma
Anthony G McCluskey, Marie Boyd, Mark N Gaze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2007
A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo
Robert J Mairs, Susan C Ross, Anthony G McCluskey, et al.
Dose-Response : a Publication of International Hormesis Society
|
July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effect
Robert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Biology
|
September 8, 2016
Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells
Colin Rae, Robert J Mairs
Oncotarget
|
February 19, 2019
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
Colin Rae, Robert J Mairs
Chirality
|
December 1, 2016
Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75
Colin Rae, John W Babich, Robert J Mairs
Nuclear Medicine and Biology
|
October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapy
Robert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
Nuclear Medicine and Biology
|
October 17, 2002
Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cells
Sean Carlin, Robert J Mairs, Phil Welsh, et al.
The Journal of Pharmacy and Pharmacology
|
July 23, 2008
Radiation quality-dependent bystander effects elicited by targeted radionuclides
Marie Boyd, Annette Sorensen, Anthony G McCluskey, et al.
Radiation Research
|
October 21, 2015
Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy
Colin Rae, Uwe Haberkorn, John W Babich, et al.
Cancer Letters
|
June 7, 2005
[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma
Anthony G McCluskey, Marie Boyd, Mark N Gaze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2007
A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo
Robert J Mairs, Susan C Ross, Anthony G McCluskey, et al.
Dose-Response : a Publication of International Hormesis Society
|
July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effect
Robert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
Page
of 3